Viewing Study NCT03562195


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-02-21 @ 7:52 PM
Study NCT ID: NCT03562195
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2018-05-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eosinophilic inflammation View
None Mepolizumab View
None Asthma View